化疗药-话题@MedSci

#化疗药#

72篇内容 | 1145人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1581788, encodeId=120f1581e8870, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, objectTitle=这些常见化疗药的禁忌症，你都弄清楚了吗？, objectType=article, longId=736890, objectId=73e1e368900f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73e1e368900f, replyNumber=0, likeNumber=40, createdTime=2022-08-26, rootId=0, userName=12498cb5m18暂无昵称, userId=298f16872689, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73e1e368900f, moduleTitle=这些常见化疗药的禁忌症，你都弄清楚了吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73e1e368900f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581787, encodeId=051b1581e8740, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, objectTitle=关于化疗药物的输注注意事项，这些你一定要知道！, objectType=article, longId=735319, objectId=326ce3531952, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=326ce3531952, replyNumber=0, likeNumber=45, createdTime=2022-08-10, rootId=0, userName=12498cb5m18暂无昵称, userId=298f16872689, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=326ce3531952, moduleTitle=关于化疗药物的输注注意事项，这些你一定要知道！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=326ce3531952)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581786, encodeId=19ac1581e86a1, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, objectTitle=如何预防和处理化疗药外渗？你想知道的都在这了, objectType=article, longId=735104, objectId=8e35e351044b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e35e351044b, replyNumber=0, likeNumber=57, createdTime=2022-08-08, rootId=0, userName=12498cb5m18暂无昵称, userId=298f16872689, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e35e351044b, moduleTitle=如何预防和处理化疗药外渗？你想知道的都在这了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e35e351044b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581785, encodeId=bcb31581e85e2, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, objectTitle=这些需要预处理的化疗药物，你不可不知！, objectType=article, longId=733073, objectId=abece330736e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=abece330736e, replyNumber=0, likeNumber=59, createdTime=2022-07-24, rootId=0, userName=12498cb5m18暂无昵称, userId=298f16872689, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=abece330736e, moduleTitle=这些需要预处理的化疗药物，你不可不知！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=abece330736e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581784, encodeId=aa0d1581e84a2, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, objectTitle=别只关心新型抗肿瘤药物，传统化疗药物也该学学了！, objectType=article, longId=732262, objectId=00d1e32262ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00d1e32262ad, replyNumber=0, likeNumber=42, createdTime=2022-07-14, rootId=0, userName=12498cb5m18暂无昵称, userId=298f16872689, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00d1e32262ad, moduleTitle=别只关心新型抗肿瘤药物，传统化疗药物也该学学了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00d1e32262ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581782, encodeId=28cc1581e82df, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, objectTitle=请收好，这份常用化疗药主要副作用及处理原则攻略, objectType=article, longId=729925, objectId=5d18e2992579, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d18e2992579, replyNumber=0, likeNumber=46, createdTime=2022-06-20, rootId=0, userName=12498cb5m18暂无昵称, userId=298f16872689, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d18e2992579, moduleTitle=请收好，这份常用化疗药主要副作用及处理原则攻略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d18e2992579)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581783, encodeId=f3021581e8395, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, objectTitle=中国研究：竟要让肿瘤患者少吃牛奶和鸡蛋？是真的！如果正在使用这个化疗药的话......, objectType=article, longId=729607, objectId=f363e2960703, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f363e2960703, replyNumber=0, likeNumber=46, createdTime=2022-06-17, rootId=0, userName=12498cb5m18暂无昵称, userId=298f16872689, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f363e2960703, moduleTitle=中国研究：竟要让肿瘤患者少吃牛奶和鸡蛋？是真的！如果正在使用这个化疗药的话......, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f363e2960703)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581781, encodeId=971e1581e81c1, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, objectTitle=一表总结，28种常用化疗药物溶媒和输注时间, objectType=article, longId=728551, objectId=6de1e28551b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6de1e28551b0, replyNumber=0, likeNumber=35, createdTime=2022-06-04, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6de1e28551b0, moduleTitle=一表总结，28种常用化疗药物溶媒和输注时间, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6de1e28551b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581780, encodeId=e0231581e80de, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, objectTitle=化疗药给药顺序分不清？一文搞懂20种常见化疗方案先后顺序, objectType=article, longId=724161, objectId=8446e24161bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8446e24161bf, replyNumber=0, likeNumber=48, createdTime=2022-04-14, rootId=0, userName=12498cb5m18暂无昵称, userId=298f16872689, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8446e24161bf, moduleTitle=化疗药给药顺序分不清？一文搞懂20种常见化疗方案先后顺序, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8446e24161bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581779, encodeId=96321581e79c9, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, objectTitle=Clin Cancer Res：Adavosertib联合各种化疗药治疗原发铂耐药的卵巢癌、输卵管癌、腹膜癌, objectType=article, longId=293566, objectId=93972935663a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93972935663a, replyNumber=0, likeNumber=32, createdTime=2022-01-09, rootId=0, userName=12498cb5m18暂无昵称, userId=298f16872689, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93972935663a, moduleTitle=Clin Cancer Res：Adavosertib联合各种化疗药治疗原发铂耐药的卵巢癌、输卵管癌、腹膜癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93972935663a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581778, encodeId=05541581e7881, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, objectTitle=Eur Urol：转移去势抵抗性前列腺癌中，一线化疗药物cabazitaxel和docetaxel的患者偏好性, objectType=article, longId=221370, objectId=59592213e0c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59592213e0c8, replyNumber=0, likeNumber=48, createdTime=2021-12-02, rootId=0, userName=12498cb5m18暂无昵称, userId=298f16872689, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59592213e0c8, moduleTitle=Eur Urol：转移去势抵抗性前列腺癌中，一线化疗药物cabazitaxel和docetaxel的患者偏好性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=59592213e0c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581777, encodeId=128f1581e770f, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, objectTitle=JAMA Netw Open：铂类化疗药物基础上加用硫代硫酸钠，患者的耳毒性风险是否会更低？, objectType=article, longId=215264, objectId=bc462152649e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc462152649e, replyNumber=0, likeNumber=46, createdTime=2021-08-05, rootId=0, userName=12498cb5m18暂无昵称, userId=298f16872689, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc462152649e, moduleTitle=JAMA Netw Open：铂类化疗药物基础上加用硫代硫酸钠，患者的耳毒性风险是否会更低？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc462152649e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581776, encodeId=20391581e76cb, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, objectTitle=Br J Cancer：抗EGFR疗法治疗结直肠癌的亚型特异性疗效取决于化疗药物选择, objectType=article, longId=214205, objectId=f8bf2142050d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8bf2142050d, replyNumber=0, likeNumber=37, createdTime=2021-07-15, rootId=0, userName=12498cb5m18暂无昵称, userId=298f16872689, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8bf2142050d, moduleTitle=Br J Cancer：抗EGFR疗法治疗结直肠癌的亚型特异性疗效取决于化疗药物选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8bf2142050d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581775, encodeId=51a41581e757a, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, objectTitle= Nat Nanotech：诱骗癌细胞摄取化疗药物，增强癌症治疗效果, objectType=article, longId=211472, objectId=bfc62114e25e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bfc62114e25e, replyNumber=0, likeNumber=37, createdTime=2021-05-19, rootId=0, userName=12498cb5m18暂无昵称, userId=298f16872689, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bfc62114e25e, moduleTitle= Nat Nanotech：诱骗癌细胞摄取化疗药物，增强癌症治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bfc62114e25e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581774, encodeId=7f901581e741f, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, objectTitle=化疗药物剂量如何把握？新的里程碑研究为有效监测癌症患者的化疗药物水平带来希望, objectType=article, longId=209580, objectId=07d02095806b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07d02095806b, replyNumber=0, likeNumber=51, createdTime=2021-04-06, rootId=0, userName=12498cb5m18暂无昵称, userId=298f16872689, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07d02095806b, moduleTitle=化疗药物剂量如何把握？新的里程碑研究为有效监测癌症患者的化疗药物水平带来希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07d02095806b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581773, encodeId=0fc11581e7361, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, objectTitle=名家共话分子分型时代下乳腺癌化疗药物的使用策略, objectType=article, longId=198884, objectId=f78719888414, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f78719888414, replyNumber=0, likeNumber=50, createdTime=2020-08-08, rootId=0, userName=12498cb5m18暂无昵称, userId=298f16872689, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f78719888414, moduleTitle=名家共话分子分型时代下乳腺癌化疗药物的使用策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f78719888414)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581772, encodeId=9bc41581e72b9, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, objectTitle=新型乳腺癌化疗药物艾立布林获NMPA批准上市, objectType=article, longId=183683, objectId=508b18368332, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=508b18368332, replyNumber=0, likeNumber=35, createdTime=2019-11-29, rootId=0, userName=12498cb5m18暂无昵称, userId=298f16872689, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=508b18368332, moduleTitle=新型乳腺癌化疗药物艾立布林获NMPA批准上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=508b18368332)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581771, encodeId=5abd1581e713e, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, objectTitle=Teva停产重要儿童化疗药辉瑞“救场”, objectType=article, longId=181414, objectId=993f18141422, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=993f18141422, replyNumber=0, likeNumber=58, createdTime=2019-10-18, rootId=0, userName=12498cb5m18暂无昵称, userId=298f16872689, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=993f18141422, moduleTitle=Teva停产重要儿童化疗药辉瑞“救场”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=993f18141422)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581770, encodeId=dff41581e7076, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, objectTitle=罗氏PD-L1单抗Tecentriq与化疗药联合治疗膀胱癌III期结果喜人, objectType=article, longId=177126, objectId=a2121e71269e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2121e71269e, replyNumber=0, likeNumber=42, createdTime=2019-08-09, rootId=0, userName=12498cb5m18暂无昵称, userId=298f16872689, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2121e71269e, moduleTitle=罗氏PD-L1单抗Tecentriq与化疗药联合治疗膀胱癌III期结果喜人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2121e71269e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581769, encodeId=62ab1581e69c2, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, objectTitle=白蛋白紫杉醇：一款纳米化疗药的前世、今生和未来, objectType=article, longId=165755, objectId=c6e9165e551d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6e9165e551d, replyNumber=0, likeNumber=47, createdTime=2019-05-11, rootId=0, userName=12498cb5m18暂无昵称, userId=298f16872689, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6e9165e551d, moduleTitle=白蛋白紫杉醇：一款纳米化疗药的前世、今生和未来, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6e9165e551d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

化疗药

2020-05-29

12498cb5m18暂无昵称 (审核中...)

前往app查看评论内容

#化疗药#

这些常见化疗药的禁忌症，你都弄清楚了吗？

2022-08-26

12498cb5m18暂无昵称 (审核中...)

前往app查看评论内容

#化疗药#

关于化疗药物的输注注意事项，这些你一定要知道！

2022-08-10

12498cb5m18暂无昵称 (审核中...)

前往app查看评论内容

#化疗药#

如何预防和处理化疗药外渗？你想知道的都在这了

2022-08-08

12498cb5m18暂无昵称 (审核中...)

前往app查看评论内容

#化疗药#

这些需要预处理的化疗药物，你不可不知！

2022-07-24

12498cb5m18暂无昵称 (审核中...)

前往app查看评论内容

#化疗药#

别只关心新型抗肿瘤药物，传统化疗药物也该学学了！

2022-07-14

12498cb5m18暂无昵称 (审核中...)

前往app查看评论内容

#化疗药#

请收好，这份常用化疗药主要副作用及处理原则攻略

2022-06-20

12498cb5m18暂无昵称 (审核中...)

前往app查看评论内容

#化疗药#

中国研究：竟要让肿瘤患者少吃牛奶和鸡蛋？是真的！如果正在使用这个化疗药的话......

2022-06-17

仁者大医 (审核中...)

前往app查看评论内容

#化疗药#

一表总结，28种常用化疗药物溶媒和输注时间

2022-06-04

12498cb5m18暂无昵称 (审核中...)

前往app查看评论内容

#化疗药#

化疗药给药顺序分不清？一文搞懂20种常见化疗方案先后顺序

2022-04-14

12498cb5m18暂无昵称 (审核中...)

前往app查看评论内容

#化疗药#

Clin Cancer Res：Adavosertib联合各种化疗药治疗原发铂耐药的卵巢癌、输卵管癌、腹膜癌

2022-01-09

12498cb5m18暂无昵称 (审核中...)

前往app查看评论内容

#化疗药#

Eur Urol：转移去势抵抗性前列腺癌中，一线化疗药物cabazitaxel和docetaxel的患者偏好性

2021-12-02

12498cb5m18暂无昵称 (审核中...)

前往app查看评论内容

#化疗药#

JAMA Netw Open：铂类化疗药物基础上加用硫代硫酸钠，患者的耳毒性风险是否会更低？

2021-08-05

12498cb5m18暂无昵称 (审核中...)

前往app查看评论内容

#化疗药#

Br J Cancer：抗EGFR疗法治疗结直肠癌的亚型特异性疗效取决于化疗药物选择

2021-07-15

12498cb5m18暂无昵称 (审核中...)

前往app查看评论内容

#化疗药#

Nat Nanotech：诱骗癌细胞摄取化疗药物，增强癌症治疗效果

2021-05-19

12498cb5m18暂无昵称 (审核中...)

前往app查看评论内容

#化疗药#

化疗药物剂量如何把握？新的里程碑研究为有效监测癌症患者的化疗药物水平带来希望

2021-04-06

12498cb5m18暂无昵称 (审核中...)

前往app查看评论内容

#化疗药#

名家共话分子分型时代下乳腺癌化疗药物的使用策略

2020-08-08

12498cb5m18暂无昵称 (审核中...)

前往app查看评论内容

#化疗药#

新型乳腺癌化疗药物艾立布林获NMPA批准上市

2019-11-29

12498cb5m18暂无昵称 (审核中...)

前往app查看评论内容

#化疗药#

Teva停产重要儿童化疗药辉瑞“救场”

2019-10-18

12498cb5m18暂无昵称 (审核中...)

前往app查看评论内容

#化疗药#

罗氏PD-L1单抗Tecentriq与化疗药联合治疗膀胱癌III期结果喜人

2019-08-09

12498cb5m18暂无昵称 (审核中...)

前往app查看评论内容

#化疗药#

白蛋白紫杉醇：一款纳米化疗药的前世、今生和未来

2019-05-11

科室
- - 订阅+
  - 更多科室
工具
服务